Ebp1 isoforms distinctively regulate cell survival and differentiation
- PMID: 16832058
- PMCID: PMC1544149
- DOI: 10.1073/pnas.0602923103
Ebp1 isoforms distinctively regulate cell survival and differentiation
Abstract
Ebp1, an ErbB3 receptor-binding protein, inhibits the proliferation and induces the differentiation of human cancer cells. Ebp1 binds nuclear Akt and prevents DNA fragmentation by inhibiting caspase-activated DNase. Here, we show that Ebp1 possesses two different isoforms, p48 and p42, which differentially mediate PC12 cell survival and differentiation. The longer-form p48 localizes in both the cytoplasm and the nucleus and suppresses apoptosis, whereas the shorter-form p42 predominantly resides in the cytoplasm and promotes cell differentiation. EGF strongly stimulates p42 to bind ErbB3, and the association depends on PKC-mediated phosphorylation of Ebp1. By contrast, p48 does not bind to ErbB3 regardless of EGF treatment. Overexpression of p48 provokes cell proliferation, which is inhibited by p42. Moreover, nerve growth factor elicits extensive sprouting in p42 stably transfected PC12 cells, whereas p48 cells reveal modest neurite outgrowth. Although mitogen-activated protein kinase cascade remains similar in both cells, Akt is more active in p48 cells than in p42 cells. Thus, Ebp1 might regulate cell survival and differentiation through two distinctive p48 and p42 isoforms.
Conflict of interest statement
Conflict of interest statement: No conflicts declared.
Figures







Similar articles
-
Ebp1 association with nucleophosmin/B23 is essential for regulating cell proliferation and suppressing apoptosis.J Biol Chem. 2007 Dec 14;282(50):36744-54. doi: 10.1074/jbc.M706169200. Epub 2007 Oct 18. J Biol Chem. 2007. PMID: 17951246
-
p48 Ebp1 acts as a downstream mediator of Trk signaling in neurons, contributing neuronal differentiation.Neurochem Int. 2011 Feb;58(2):215-23. doi: 10.1016/j.neuint.2010.12.001. Epub 2010 Dec 8. Neurochem Int. 2011. PMID: 21145366
-
Nuclear Akt associates with PKC-phosphorylated Ebp1, preventing DNA fragmentation by inhibition of caspase-activated DNase.EMBO J. 2006 May 17;25(10):2083-95. doi: 10.1038/sj.emboj.7601111. Epub 2006 Apr 27. EMBO J. 2006. PMID: 16642037 Free PMC article.
-
Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells.Int J Cancer. 2016 Sep 15;139(6):1202-8. doi: 10.1002/ijc.30165. Epub 2016 May 17. Int J Cancer. 2016. PMID: 27130196 Review.
-
The structure and function of multifunctional protein ErbB3 binding protein 1 (Ebp1) and its role in diseases.Cell Biol Int. 2024 Aug;48(8):1069-1079. doi: 10.1002/cbin.12196. Epub 2024 Jun 17. Cell Biol Int. 2024. PMID: 38884348 Review.
Cited by
-
Cerebellar dysfunction and schizophrenia-like behavior in Ebp1-deficient mice.Mol Psychiatry. 2022 Apr;27(4):2030-2041. doi: 10.1038/s41380-022-01458-1. Epub 2022 Feb 15. Mol Psychiatry. 2022. PMID: 35165395
-
EBP1 and DRBP76/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon.Nucleic Acids Res. 2011 Sep 1;39(16):7263-75. doi: 10.1093/nar/gkr278. Epub 2011 May 29. Nucleic Acids Res. 2011. PMID: 21624892 Free PMC article.
-
ERBB3-Binding Protein 1 (EBP1) Is a Novel Developmental Pluripotency-Associated-4 (DPPA4) Cofactor in Human Pluripotent Cells.Stem Cells. 2018 May;36(5):671-682. doi: 10.1002/stem.2776. Epub 2018 Jan 29. Stem Cells. 2018. PMID: 29327467 Free PMC article.
-
Knockdown of EBP1 promotes doxorubicin-induced apoptosis in renal clear cell carcinoma cells through activation of the p38/HIF-1α pathway.Oncol Lett. 2025 Feb 6;29(4):172. doi: 10.3892/ol.2025.14918. eCollection 2025 Apr. Oncol Lett. 2025. PMID: 39968014 Free PMC article.
-
Structural insights into the transcriptional and translational roles of Ebp1.EMBO J. 2007 Sep 5;26(17):3936-44. doi: 10.1038/sj.emboj.7601817. Epub 2007 Aug 9. EMBO J. 2007. PMID: 17690690 Free PMC article.
References
-
- Lessor T. J., Hamburger A. W. Mol. Cell. Endocrinol. 2001;175:185–191. - PubMed
-
- Lessor T. J., Yoo J. Y., Xia X., Woodford N., Hamburger A. W. J. Cell. Physiol. 2000;183:321–329. - PubMed
-
- Radomski N., Jost E. Exp. Cell Res. 1995;220:434–445. - PubMed
-
- Squatrito M., Mancino M., Donzelli M., Areces L. B., Draetta G. F. Oncogene. 2004;23:4454–4465. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials